MAPT and Alzheimer disease: It has been extensively reported that tau181, tau 217 and tau 231 are desired biomarkers for early diagnosis of AD [25, 26], and brain-derived tau aggregate seeds can spread tauopathy throughout the brain, further inducing the mis-folding of endogenous tau and neuronal degeneration [6, 11].